2-(nitrooxy)ethyl apovincaminate and Breast Cancer

2-(nitrooxy)ethyl apovincaminate has been researched along with Breast Cancer in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Babilonia, MB; Bower, J; Cole, S; Culakova, E; Desta, Z; Han, HS; Heckler, C; Hoogland, AI; Janelsins, M; Jim, HSL; Morrow, G; Peppone, L; Williams, GC	1

Trials

1 trial(s) available for 2-(nitrooxy)ethyl apovincaminate and Breast Cancer

Article	Year
A randomized placebo-controlled trial of bupropion for Cancer-related fatigue: Study design and procedures. Contemporary clinical trials, 2020, Volume: 91 Topics: Age Factors; Antidepressive Agents, Second-Generation; Breast Neoplasms; Bupropion; Cancer Survivors; Cytochrome P-450 CYP2B6; Delayed-Action Preparations; Depression; Double-Blind Method; Fatigue; Female; Health Behavior; Humans; Menopause; Quality of Life; Research Design; Socioeconomic Factors; Vinca Alkaloids	2020

Article

Year

A randomized placebo-controlled trial of bupropion for Cancer-related fatigue: Study design and procedures.

Contemporary clinical trials, 2020, Volume: 91

Topics: Age Factors; Antidepressive Agents, Second-Generation; Breast Neoplasms; Bupropion; Cancer Survivors; Cytochrome P-450 CYP2B6; Delayed-Action Preparations; Depression; Double-Blind Method; Fatigue; Female; Health Behavior; Humans; Menopause; Quality of Life; Research Design; Socioeconomic Factors; Vinca Alkaloids

2020